Department of Medicine News and Stories

John J. Reilly, Jr., Dean of the University of Colorado School of Medicine and vice chancellor for health affairs at CU Anschutz, said the $50 million donation provides scientists the funding to “move initiatives forward more rapidly and make an immediate impact in medicine.”

“If chatbots are patients’ so-called ‘first touch’ with the health care system, we really need to understand how they experience them and what the effects could be on trust and compassion,” says Annie Moore, a professor of internal medicine, in a university release.

The currently available CF drugs, called CFTR modulators, are designed to bind to and correct aberrant CFTR protein, said Jennifer Taylor-Cousar, who treats cystic fibrosis in adults and children at National Jewish Health in Denver, Colorado [and professor of medicine at CU School of Medicine] and co-authored a 2023 review article on modulator therapies.

What happens when homeless encampments are swept away? Dr. Joshua Barocas, an infectious disease physician at the University of Colorado School of Medicine, talks with Dr. Josh Sharfstein about a new study that simulates the true cost of “move along” orders and encampment “clean ups"—including infectious disease outbreaks, hospitalizations and deaths. They then discuss the short-term and long-term implications of these findings.